Dermatitis Herpetiformis: The Skin and the Gut
- STEPHEN I. KATZ, M.D., Ph.D.;
- RUSSELL P. HALL III, M.D.;
- THOMAS J. LAWLEY, M.D.; and
- WARREN STROBER, M.D.
Abstract
Dermatitis herpetiformis is an intensely itchy, chronic, papulovesicular eruption that is usually symmetrically distributed on extensor surfaces. Histologically, it is characterized by dermal papillary collections of neutrophils and subepidermal vesicle formation. The skin has IgA deposits in areas corresponding to the earliest histopathologic change; that is, at the epidermal-dermal junction. Most patients have an associated asymptomatic gluten-sensitive enteropathy that mimics ordinary glutensensitive enteropathy (celiac disease) both morphologically and in its response to gluten protein. There is a marked increase in the prevalence of the major histocompatibility antigens, HLA-B8 and HLA-Dw3, and in certain B cell antigens in these patients. Although the sulfones or sulfapyridine have been the mainstay of treatment, it is now clear that the skin disease responds to strict adherence to a gluten-free diet. These findings are reviewed and from them are drawn certain conclusions as to possible pathophysiologic mechanisms involved in dermatitis herpetiformis.
Article and Author Information
-
▸An edited transcription of a Combined Clinical Staff Conference at the Clinical Center, Bethesda, Maryland, 21 February 1980, by the National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services.
-
▸Authors who wish to cite a section of this conference and specifically indicate its author can use this example for the form of reference:
LAWLEY TJ. Reticuloendothelial system function, p. 863. In: KATZ SI, moderator. Dermatitis herpetiformis: the skin and the gut. Ann Intern Med. 1980;93:857-74.
-
▸Requests for reprints should be addressed to Stephen I. Katz, M.D.; Building 10, Room 12N238, Dermatology Branch, National Cancer Institute; Bethesda, MD 20205.
RSS Feeds









